Flexible dual-channel LED controller for 48V automotive LDMs, supporting 5-80V multi-topology designsMILPITAS, Calif., June 08, 2026 (GLOBE NEWSWIRE) -- Lumissil Microsystems today unveiled the IS32LT ...
Veteran UK executive will help build the company's reinsurance capability and expand its senior-market business.GREENWICH, Conn., June 8, 2026 /PRNewswire/ -- Lumos Insurance, a wholly owned ...
Results from Rhapsido (remibrutinib) pivotal Phase III RemIND trial, the largest study in chronic inducible urticaria, to be highlighted in late-breaker oral presentationNew Phase IIIb REMIXED extensi ...
As pressure mounts on young people to decide what comes next, growing numbers are choosing international experiences to gain clarity, confidence and real-world skills. Zurich, 8 June 2026 - Across ...
TARS DexHand Signals a New Era of Hand-Brain IntegrationVIENNA, June 8, 2026 /PRNewswire/ -- TARS capped a landmark appearance at ICRA 2026, IEEE's leading international robotics conference ...
UGREEN today introduced NASync DXP GT, a new Network-Attached Storage (NAS) lineup built for content creators, smart home users, and users with growing storage ...
During the period June 1 - June 5, 2026, Telefonaktiebolaget LM Ericsson (publ) ("Ericsson") (LEI code 549300W9JLPW15XIFM52) repurchased own Class B shares ...
Musim Mas, a leading integrated oleochemical group, has been awarded an 'A' in the Supplier Engagement Assessment (SEA) for the second time since 2024 ...
Largest professional services network recognizes Configit's excellent management across four key functionsCOPENHAGEN, Denmark, June 8, 2026 /PRNewswire/ -- Configit, the global leader in Configuration ...
Tethis S.p.A., a pioneering life sciences and diagnostics company, today announces the commercial launch of SmartBioSurface slides, an innovative solution ...
New York Residence, Inc., a world-renowned real estate brokerage firm, launches an international tour to connect with European investors. Chief Financial ...
LUND, SE / ACCESS Newswire / June 8, 2026 / Alligator Bioscience (STO:ATORX) today comments on a recent update regarding patient recruitment in the ongoing Phase 3 clinical trial of HLX22, developed b ...